Nomura keeps neutral rating on Fortis Healthcare, target Rs 1,030
Nomura retained a “neutral” rating on Fortis Healthcare and kept its target price at Rs. 1,030 per share, citing that the rating is based on 25x FY28-29F average EBITDA and that growth is priced in while EBITDA margin expansion faces headwinds from ES…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.